Back

Prevention of new-onset heart failure and renoprotective effect with sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Prevention of heart failure Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yuki Gonda

University hospital Bonn, Bonn (Germany)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor W. Shi (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Mrs D. Gjermeni (Stanford, US)
Abstract
Presentation thumbnail
Mr K. Raveendra (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Doctor U. Aslan (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Prevention of heart failure

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure
thumbnail
Congress Presentation
Safety and efficacy of initiation SGLT in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease on top of standard therapy with ARNI or ACE-i
thumbnail
Congress Presentation
Guideline-directed medical therapy use in patients with incident comorbid heart failure and chronic kidney disease (The CaRe Study)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources